Skip to Content

Showing 1-1 of 1

Sorted By:

  • BRILINTA AD HOC PCI

    The purpose of this study is to assess the pharmacodynamic effect of ticagrelor in ACS patients undergoing an Ad Hoc PCI.

Showing trial 1 of 1

Also in this Section